Detalles de la búsqueda
1.
Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
Ann Hematol
; 100(10): 2513-2519, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34279675
2.
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Br J Haematol
; 165(3): 382-91, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24506200
3.
Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma.
Biol Blood Marrow Transplant
; 19(1): 123-8, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22940055
4.
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
J Hematol Oncol
; 16(1): 122, 2023 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104096
5.
Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.
Br J Haematol
; 158(2): 216-231, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22571278
6.
Late relapse in patients with diffuse large B-cell lymphoma.
Br J Haematol
; 151(4): 354-8, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20880118
7.
Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.
Mol Cancer Res
; 6(12): 1928-36, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19074837
8.
Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma.
Hum Pathol
; 72: 180-190, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29170017
9.
The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.
Br J Haematol
; 157(3): 401-3, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22224728
10.
Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.
Cancer Genet Cytogenet
; 172(2): 120-6, 2007 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17213020
11.
Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation.
Leuk Lymphoma
; 48(4): 683-90, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17454625
12.
Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Int J Mol Med
; 20(4): 461-9, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17786276
13.
Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy.
Clin Lymphoma Myeloma Leuk
; 17(8): 488-497.e2, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28842137
14.
Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome.
Leuk Lymphoma
; 56(11): 3082-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25827211
15.
A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.
Blood
; 101(6): 2363-7, 2003 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12424193
Resultados
1 -
15
de 15
1
Próxima >
>>